Ocrelizumab
Twice-yearly infusion for relapsing and primary progressive MS.
- Starts working
- Weeks to months
- Half-life
- About 26 days
- In use since
- —
- Pregnancy
- Usually avoided
Overview
Ocrelizumab depletes B cells and is the first treatment approved for primary progressive MS. It is given as an infusion twice a year and increases infection risk.
Conditions it's used for
How it works
Removes immune B cells that drive MS damage.
Ocrelizumab belongs to the Multiple sclerosis therapies. How Multiple sclerosis therapies work: calm or redirect the immune system so it attacks the nerve coating less.
Uses
- Relapsing MS
- Primary progressive MS
Available as: iv infusion every 6 months, subcutaneous injection (some regions).
Typical dose
- Adults
- 300 mg IV twice two weeks apart, then 600 mg every 6 months.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Infusion reactions
- Respiratory infections
- Herpes infections
Serious — get medical help
Uncommon, but need prompt attention
- Serious infections
- Hepatitis B reactivation
- Possible increase in breast cancer
- PML (rare)
Warnings
- Hepatitis B screening before starting
- Pre-medication reduces infusion reactions
Who should avoid it
- Active hepatitis B
- Active serious infection
Interactions
- Other immunosuppressants — added infection risk
- Live vaccines — avoid
Using it safely
- Alcohol
- Usually no problem in moderation. No known interaction.
- Food and drink
- Not applicable.
- If you miss a dose
- Contact the infusion centre.
- Stopping it
- Stop only on specialist advice.
- Driving
- Infusion reactions may affect alertness the same day.
- Tests and checks
- Hepatitis B status; Immunoglobulin levels; Infections
- If too much is taken
- Seek advice.
- Storage
- Refrigerate.
- Legal status
- United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule HAustralia: Prescription only (Schedule 4)
Pregnancy and breastfeeding
Pregnancy
Usually avoided
Avoid unless needed; contraception advised.
Breastfeeding
Use with caution
Large antibody; limited data.
Special groups
- Kidney disease
- No adjustment.
- Liver disease
- Use caution.
- Older adults
- Limited data.
Brand names
- United States
- Ocrevus
- United Kingdom
- Ocrevus
- India
- Ocrevus
- Australia
- Ocrevus
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Do I need a prescription for Ocrelizumab?
Yes — Ocrelizumab is prescription-only in most countries.
Can I take Ocrelizumab during pregnancy?
Usually avoided. Avoid unless needed; contraception advised. Always check with a doctor or midwife.
How quickly does Ocrelizumab work?
Weeks to months.
Related medicines
Natalizumab
Highly effective infusion for MS with a risk of PML.
RxMultiple sclerosis therapiesRituximab
Antibody that clears B-cells — for lymphoma and autoimmune disease.
RxWHOTargeted antibodiesFingolimod
First oral therapy for relapsing multiple sclerosis.
RxMultiple sclerosis therapiesDimethyl fumarate
Oral MS therapy with flushing and stomach upset in the first months.
RxMultiple sclerosis therapiesGlatiramer acetate
Injection for relapsing MS with no flu-like effects.
RxMultiple sclerosis therapiesInterferon beta
Injectable disease-modifying therapy for relapsing multiple sclerosis.
RxMultiple sclerosis therapies
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — L04AG08
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.